Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shu-Ching Hu

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
Neurology|May 12, 2025
The Parkinson's Disease Composite of Executive Functioning: A Measure for Detecting Cognitive Decline in Clinical TrialsChristina B Young, Brenna Cholerton, Alena M Smith, et al.
Neurology|June 13, 2024
The Parkinson's Disease Composite of Executive Functioning: A Measure for Detecting Cognitive Decline in Clinical TrialsChristina B Young, Brenna Cholerton, Alena M Smith, et al.
Clinical Parkinsonism & Related Disorders|May 30, 2023
Gait and balance in apolipoprotein Ɛ4 allele carriers in older adults and Parkinson's diseaseRosie Morris, Douglas N Martini, Valerie E Kelly, et al.
Acta Neuropathologica|July 7, 2014
Plasma exosomal α-synuclein is likely CNS-derived and increased in Parkinson's diseaseMin Shi, Changqin Liu, Travis J Cook, et al.
NPJ Parkinson'S Disease|June 20, 2022
Cognition as a mediator for gait and balance impairments in GBA-related Parkinson's diseaseRosie Morris, Douglas N Martini, Katrina Ramsey, et al.
Parkinsonism & Related Disorders|February 27, 2018
Sex differences in progression to mild cognitive impairment and dementia in Parkinson's diseaseBrenna Cholerton, Catherine O Johnson, Brian Fish, et al.
Metabolites|April 21, 2022
Predictive Modeling of Alzheimer's and Parkinson's Disease Using Metabolomic and Lipidomic Profiles from Cerebrospinal FluidNathan Hwangbo, Xinyu Zhang, Daniel Raftery, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 29, 2016
CNS tau efflux via exosomes is likely increased in Parkinson's disease but not in Alzheimer's diseaseMin Shi, Andrej Kovac, Ane Korff, et al.
Neurobiology of Aging|May 21, 2017
Large-scale exploratory genetic analysis of cognitive impairment in Parkinson's diseaseIgnacio F Mata, Catherine O Johnson, James B Leverenz, et al.
JAMA Neurology|September 3, 2014
APOE, MAPT, and SNCA genes and cognitive performance in Parkinson diseaseIgnacio F Mata, James B Leverenz, Daniel Weintraub, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Neurology|May 12, 2025
The Parkinson's Disease Composite of Executive Functioning: A Measure for Detecting Cognitive Decline in Clinical TrialsChristina B Young, Brenna Cholerton, Alena M Smith, et al.
Neurology|June 13, 2024
The Parkinson's Disease Composite of Executive Functioning: A Measure for Detecting Cognitive Decline in Clinical TrialsChristina B Young, Brenna Cholerton, Alena M Smith, et al.
Clinical Parkinsonism & Related Disorders|May 30, 2023
Gait and balance in apolipoprotein Ɛ4 allele carriers in older adults and Parkinson's diseaseRosie Morris, Douglas N Martini, Valerie E Kelly, et al.
Acta Neuropathologica|July 7, 2014
Plasma exosomal α-synuclein is likely CNS-derived and increased in Parkinson's diseaseMin Shi, Changqin Liu, Travis J Cook, et al.
NPJ Parkinson'S Disease|June 20, 2022
Cognition as a mediator for gait and balance impairments in GBA-related Parkinson's diseaseRosie Morris, Douglas N Martini, Katrina Ramsey, et al.
Parkinsonism & Related Disorders|February 27, 2018
Sex differences in progression to mild cognitive impairment and dementia in Parkinson's diseaseBrenna Cholerton, Catherine O Johnson, Brian Fish, et al.
Metabolites|April 21, 2022
Predictive Modeling of Alzheimer's and Parkinson's Disease Using Metabolomic and Lipidomic Profiles from Cerebrospinal FluidNathan Hwangbo, Xinyu Zhang, Daniel Raftery, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 29, 2016
CNS tau efflux via exosomes is likely increased in Parkinson's disease but not in Alzheimer's diseaseMin Shi, Andrej Kovac, Ane Korff, et al.
Neurobiology of Aging|May 21, 2017
Large-scale exploratory genetic analysis of cognitive impairment in Parkinson's diseaseIgnacio F Mata, Catherine O Johnson, James B Leverenz, et al.
JAMA Neurology|September 3, 2014
APOE, MAPT, and SNCA genes and cognitive performance in Parkinson diseaseIgnacio F Mata, James B Leverenz, Daniel Weintraub, et al.
Pageof 6